These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 11368017

  • 1. Characterization of the inhibition of protein degradation by insulin in L6 cells.
    Fawcett J, Hamel FG, Duckworth WC.
    Arch Biochem Biophys; 2001 Jan 15; 385(2):357-63. PubMed ID: 11368017
    [Abstract] [Full Text] [Related]

  • 2. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC, Bennett RG, Hamel FG.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):390-4. PubMed ID: 9514933
    [Abstract] [Full Text] [Related]

  • 3. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
    Hamel FG, Fawcett J, Tsui BT, Bennett RG, Duckworth WC.
    Diabetes Obes Metab; 2006 Nov 17; 8(6):661-8. PubMed ID: 17026490
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-I blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways: 2002 ABA paper.
    Li BG, Hasselgren PO, Fang CH, Warden GD.
    J Burn Care Rehabil; 2004 Nov 17; 25(1):112-8. PubMed ID: 14726748
    [Abstract] [Full Text] [Related]

  • 5. [Effect of dexamethasone on degradation of cultured myotube protein and its mechanism].
    Shen CA, Chai JK, Yao YM, Sheng ZY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Mar 17; 18(3):129-31. PubMed ID: 16524497
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of the lysosomal, Ca2+-dependent and ubiquitin/proteasome-dependent proteolytic pathways in fast-twitch and slow-twitch rat muscle following hyperinsulinaemia.
    Larbaud D, Balage M, Taillandier D, Combaret L, Grizard J, Attaix D.
    Clin Sci (Lond); 2001 Dec 17; 101(6):551-8. PubMed ID: 11724638
    [Abstract] [Full Text] [Related]

  • 7. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
    Huan JY, Streicher JM, Bleyle LA, Koop DR.
    Toxicol Appl Pharmacol; 2004 Sep 15; 199(3):332-43. PubMed ID: 15364548
    [Abstract] [Full Text] [Related]

  • 8. Degradation of connexin43 gap junctions involves both the proteasome and the lysosome.
    Laing JG, Tadros PN, Westphale EM, Beyer EC.
    Exp Cell Res; 1997 Nov 01; 236(2):482-92. PubMed ID: 9367633
    [Abstract] [Full Text] [Related]

  • 9. Insulin inhibition of protein degradation in cell monolayers.
    Ballard FJ, Wong SS, Knowles SE, Partridge NC, Martin TJ, Wood CM, Gunn JM.
    J Cell Physiol; 1980 Nov 01; 105(2):335-46. PubMed ID: 7007398
    [Abstract] [Full Text] [Related]

  • 10. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
    Ferrara P, Andermarcher E, Bossis G, Acquaviva C, Brockly F, Jariel-Encontre I, Piechaczyk M.
    Oncogene; 2003 Mar 13; 22(10):1461-74. PubMed ID: 12629509
    [Abstract] [Full Text] [Related]

  • 11. Proteolytic degradation of tyrosine nitrated proteins.
    Souza JM, Choi I, Chen Q, Weisse M, Daikhin E, Yudkoff M, Obin M, Ara J, Horwitz J, Ischiropoulos H.
    Arch Biochem Biophys; 2000 Aug 15; 380(2):360-6. PubMed ID: 10933892
    [Abstract] [Full Text] [Related]

  • 12. Cellular and viral Fos proteins are degraded by different proteolytic systems.
    Acquaviva C, Salvat C, Brockly F, Bossis G, Ferrara P, Piechaczyk M, Jariel-Encontre I.
    Oncogene; 2001 Feb 22; 20(8):942-50. PubMed ID: 11314029
    [Abstract] [Full Text] [Related]

  • 13. Degradation of sarcomeric and cytoskeletal proteins in cultured skeletal muscle cells.
    Purintrapiban J, Wang MC, Forsberg NE.
    Comp Biochem Physiol B Biochem Mol Biol; 2003 Nov 22; 136(3):393-401. PubMed ID: 14602148
    [Abstract] [Full Text] [Related]

  • 14. Branched-chain amino acids: a role in skeletal muscle proteolysis in catabolic states?
    Busquets S, Alvarez B, López-Soriano FJ, Argilés JM.
    J Cell Physiol; 2002 Jun 22; 191(3):283-9. PubMed ID: 12012323
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the control and pathways for degradation of the acetylcholine receptor and average protein in cultured muscle cells.
    Libby P, Goldberg AL.
    J Cell Physiol; 1981 May 22; 107(2):185-94. PubMed ID: 7019224
    [Abstract] [Full Text] [Related]

  • 16. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation.
    Crystal AS, Morais VA, Fortna RR, Carlin D, Pierson TC, Wilson CA, Lee VM, Doms RW.
    Biochemistry; 2004 Mar 30; 43(12):3555-63. PubMed ID: 15035625
    [Abstract] [Full Text] [Related]

  • 17. Regulation of intracellular protein degradation in IMR-90 human diploid fibroblasts.
    Auteri JS, Okada A, Bochaki V, Dice JF.
    J Cell Physiol; 1983 May 30; 115(2):167-74. PubMed ID: 6341382
    [Abstract] [Full Text] [Related]

  • 18. Determining protein half-lives.
    Zhou P.
    Methods Mol Biol; 2004 May 30; 284():67-77. PubMed ID: 15173609
    [Abstract] [Full Text] [Related]

  • 19. Treatment of cultured myotubes with the calcium ionophore A23187 increases proteasome activity via a CaMK II-caspase-calpain-dependent mechanism.
    Menconi MJ, Wei W, Yang H, Wray CJ, Hasselgren PO.
    Surgery; 2004 Aug 30; 136(2):135-42. PubMed ID: 15300172
    [Abstract] [Full Text] [Related]

  • 20. Pentoxifylline inhibits Ca2+-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats.
    Baviera AM, Zanon NM, Carvalho Navegantes LC, Migliorini RH, do Carmo Kettelhut I.
    Am J Physiol Endocrinol Metab; 2007 Mar 30; 292(3):E702-8. PubMed ID: 17077345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.